Taikang Asset Management (HK)’s Crinetics Pharmaceuticals CRNX Stock Holding History

Taikang Asset Management (HK)’s Portfolio CRNX Stock Details CRNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell
2025 Q1	$285K	Hold
2024 Q4	$435K	Hold
2024 Q3	$434K	Hold
2024 Q2	$381K	Buy